122 related articles for article (PubMed ID: 38169056)
21. Short-term preseasonal birch pollen allergoid immunotherapy influences symptoms, specific nasal provocation and cytokine levels in nasal secretions, but not peripheral T-cell responses, in patients with allergic rhinitis.
Klimek L; Dormann D; Jarman ER; Cromwell O; Riechelmann H; Reske-Kunz AB
Clin Exp Allergy; 1999 Oct; 29(10):1326-35. PubMed ID: 10520053
[TBL] [Abstract][Full Text] [Related]
22. Immunological effects of adjuvanted low-dose allergoid allergen-specific immunotherapy in experimental murine house dust mite allergy.
Heldner A; Alessandrini F; Russkamp D; Heine S; Schnautz B; Chaker A; Mwange J; Carreno Velazquez TL; Heath MD; Skinner MA; Kramer MF; Zissler UM; Schmidt-Weber CB; Blank S
Allergy; 2022 Mar; 77(3):907-919. PubMed ID: 34287971
[TBL] [Abstract][Full Text] [Related]
23. Long-term effects of pollen allergoid tyrosine-adsorbed subcutaneous immunotherapy on allergic rhinitis and asthma.
Vogelberg C; Klimek L; Kruppert S; Becker S
Clin Exp Allergy; 2024 Apr; 54(4):253-264. PubMed ID: 38146840
[TBL] [Abstract][Full Text] [Related]
24. Cry j 1-induced synthesis of interleukin-5 and interferon-gamma by peripheral blood mononuclear cells of patients with seasonal allergic rhinitis due to Japanese cedar pollens.
Nakai Y; Ohashi Y; Tanaka A; Kakinoki Y; Washio Y; Masamoto T; Yamada K; Nakai Y; Ohmoto Y
Acta Otolaryngol Suppl; 1998; 538():143-51. PubMed ID: 9879414
[TBL] [Abstract][Full Text] [Related]
25. Treatment with grass allergen peptides improves symptoms of grass pollen-induced allergic rhinoconjunctivitis.
Ellis AK; Frankish CW; O'Hehir RE; Armstrong K; Steacy L; Larché M; Hafner RP
J Allergy Clin Immunol; 2017 Aug; 140(2):486-496. PubMed ID: 28236469
[TBL] [Abstract][Full Text] [Related]
26. Ex Vivo Immunomodulatory Effects of Lactobacillus-, Lacticaseibacillus-, and Bifidobacterium-Containing Synbiotics on Human Peripheral Blood Mononuclear Cells and Monocyte-Derived Dendritic Cells in the Context of Grass Pollen Allergy.
Heldner A; Heath MD; Schnautz B; Kotz S; Chaker A; Kramer MF; Jakwerth CA; Zissler UM; Schmidt-Weber CB; Blank S
Probiotics Antimicrob Proteins; 2023 Aug; 15(4):868-879. PubMed ID: 35113319
[TBL] [Abstract][Full Text] [Related]
27. Nasal allergen-neutralizing IgG
Shamji MH; Kappen J; Abubakar-Waziri H; Zhang J; Steveling E; Watchman S; Kouser L; Eifan A; Switzer A; Varricchi G; Marone G; Couto-Francisco NC; Calderon M; Durham SR
J Allergy Clin Immunol; 2019 Mar; 143(3):1067-1076. PubMed ID: 30445057
[TBL] [Abstract][Full Text] [Related]
28. Preseasonal local allergoid immunotherapy to grass pollen in children: a double-blind, placebo-controlled, randomized trial.
Caffarelli C; Sensi LG; Marcucci F; Cavagni G
Allergy; 2000 Dec; 55(12):1142-7. PubMed ID: 11117271
[TBL] [Abstract][Full Text] [Related]
29. A phase 3 trial assessing the efficacy and safety of grass allergy immunotherapy tablet in subjects with grass pollen-induced allergic rhinitis with or without conjunctivitis, with or without asthma.
Murphy K; Gawchik S; Bernstein D; Andersen J; Pedersen MR
J Negat Results Biomed; 2013 Jun; 12():10. PubMed ID: 23725348
[TBL] [Abstract][Full Text] [Related]
30. Seasonal changes in phytohemagglutinin-induced cytokine synthesis by peripheral blood lymphocytes of patients with seasonal allergic rhinitis due to Japanese cedar pollens.
Tsuda M; Ohashi Y; Washio Y; Kakinoki Y; Nakai Y; Tanaka A; Nakai Y
Acta Otolaryngol Suppl; 1998; 538():156-68. PubMed ID: 9879416
[TBL] [Abstract][Full Text] [Related]
31. Clinical efficacy of microencapsulated timothy grass pollen extract in grass-allergic individuals.
TePas EC; Hoyte EG; McIntire JJ; Umetsu DT
Ann Allergy Asthma Immunol; 2004 Jan; 92(1):25-31. PubMed ID: 14756461
[TBL] [Abstract][Full Text] [Related]
32. Safety and efficacy of immunotherapy with the recombinant B-cell epitope-based grass pollen vaccine BM32.
Niederberger V; Neubauer A; Gevaert P; Zidarn M; Worm M; Aberer W; Malling HJ; Pfaar O; Klimek L; Pfützner W; Ring J; Darsow U; Novak N; Gerth van Wijk R; Eckl-Dorna J; Focke-Tejkl M; Weber M; Müller HH; Klinger J; Stolz F; Breit N; Henning R; Valenta R
J Allergy Clin Immunol; 2018 Aug; 142(2):497-509.e9. PubMed ID: 29361332
[TBL] [Abstract][Full Text] [Related]
33. Polyvalent Mechanical Bacterial Lysate Administration Improves the Clinical Course of Grass Pollen-Induced Allergic Rhinitis in Children: A Randomized Controlled Trial.
Janeczek K; Emeryk A; Rachel M; Duma D; Zimmer Ł; Poleszak E
J Allergy Clin Immunol Pract; 2021 Jan; 9(1):453-462. PubMed ID: 32858239
[TBL] [Abstract][Full Text] [Related]
34. Pollinex Quattro: an innovative four injections immunotherapy in allergic rhinitis.
Rosewich M; Lee D; Zielen S
Hum Vaccin Immunother; 2013 Jul; 9(7):1523-31. PubMed ID: 23584250
[TBL] [Abstract][Full Text] [Related]
35. Allergoid-specific T-cell reaction as a measure of the immunological response to specific immunotherapy (SIT) with a Th1-adjuvanted allergy vaccine.
von Baehr V; Hermes A; von Baehr R; Scherf HP; Volk HD; Fischer von Weikersthal-Drachenberg KJ; Woroniecki S
J Investig Allergol Clin Immunol; 2005; 15(4):234-41. PubMed ID: 16433203
[TBL] [Abstract][Full Text] [Related]
36. Accelerated Dose Escalation with Three Injections of an Aluminum Hydroxide-Adsorbed Allergoid Preparation of Six Grasses Is Safe for Patients with Moderate to Severe Allergic Rhinitis.
Kopp MV; Bovermann X; Klimek L
Int Arch Allergy Immunol; 2020; 181(2):94-102. PubMed ID: 31865326
[TBL] [Abstract][Full Text] [Related]
37. Randomized controlled trials define shape of dose response for Pollinex Quattro Birch allergoid immunotherapy.
Worm M; Higenbottam T; Pfaar O; Mösges R; Aberer W; Gunawardena K; Wessiepe D; Lee D; Kramer MF; Skinner M; Lees B; Zielen S
Allergy; 2018 Sep; 73(9):1812-1822. PubMed ID: 29779247
[TBL] [Abstract][Full Text] [Related]
38. Detection of pan-allergens in commercial pollen extracts for allergen immunotherapy.
Asero R; Mistrello G; Amato S
Ann Allergy Asthma Immunol; 2016 Aug; 117(2):180-5. PubMed ID: 27238577
[TBL] [Abstract][Full Text] [Related]
39. Sublingual immunotherapy with once-daily grass allergen tablets: a randomized controlled trial in seasonal allergic rhinoconjunctivitis.
Durham SR; Yang WH; Pedersen MR; Johansen N; Rak S
J Allergy Clin Immunol; 2006 Apr; 117(4):802-9. PubMed ID: 16630937
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
